Our read is that the ketogenic diet is well-supported for certain applications, but its long-term effects and suitability for all individuals remain a subject of ongoing discussion.
The ketogenic diet, particularly when composed of real whole foods, can lead to significant weight loss and improve numerous metabolic biomarkers, according to Peter Attia. Paul Saladino notes that ketosis is an adaptive state for humans, distinct from starvation, and the evidence for its harm is not substantial. However, concerns about long-term effects and potential detriments to human health in perpetual chronic ketosis have been raised by Paul Saladino.
Classical ketogenic diets, used for pediatric epilepsy, are typically 90% fat (e.g., 4:1 ratio), while modified versions like modified Atkins or low glycemic index therapy are more liberal (e.g., 1:1 ratio) and can produce a mild state of ketosis suitable for lifestyle, as Rhonda Patrick explains. Peter Attia advises prioritizing unsaturated fats from nuts, seeds, extra virgin olive oil, avocados, and oily fish over cream, cheese, butter, and red meat. Paul Saladino suggests that athletes on ketogenic diets and heavy exercise may benefit from consuming up to 15 grams of sodium chloride per day.
Paul Saladino expresses concerns about the long-term effects of ketogenic diets and believes that long-term ketosis is detrimental to human health, with perpetual chronic ketosis no longer favored. Rhonda Patrick states that the carnivore diet is considered sub-optimal compared to a well-designed ketogenic diet and warns that a ketogenic diet can be deadly for individuals with carnitine transferase (CPT1) deficiency. She also points out that increased fatty acid metabolism in many cancers is a reason why ketogenic diets are not beneficial for all cancer types. Paul Saladino cautions that focusing excessively on ketone levels can lead to limiting protein intake to a detrimental degree and that a ketogenic carnivore diet led to electrolyte insufficiency and feeling generally horrible for him. He also notes that ketosis is not necessarily muscle-sparing, citing personal experience of significant muscle loss, and that prolonged adherence to a ketogenic or zero-carb diet may lead to metabolic issues such as persistent insulin resistance, hormonal decline, and electrolyte imbalances. Peter Attia states that a ketogenic diet does not inherently cause a person to burn significantly more energy than a balanced diet at the same caloric intake. Rhonda Patrick also highlights that some products marketed as 'keto' contain added sugar, leading to significant glycemic spikes.
The verdict could change with further understanding of the long-term effects of ketogenic diets on the microbiome, including diversity and dysbiosis, as noted by Andrew Huberman. Paul Saladino also points to uncertainty regarding the impact of ketogenic diets on muscle growth and maintenance, and whether humans should be in a constant state of ketosis. Peter Attia raises questions about the ketogenic diet's potential negative impact on women's fertility and its optimal application for professional athletes during competitive seasons. The belief that APOE4 genotype makes individuals unsuitable for a ketogenic diet is not definitively proven, according to Paul Saladino.
Individuals transitioning from a ketogenic diet to a higher-carbohydrate diet may perform poorly on glucose tolerance tests for a few weeks.
Tracking calories is essential on a ketogenic diet, as it is easy to overeat due to the caloric density of fats.
Ketogenic diets result in low insulin, low IGF-1, and suppression of mTOR due to moderated protein intake.
Ketogenic or carnivore diets can lead to significantly lower T4 and T3 thyroid hormones, indicating a suboptimal metabolic thermostat.
Consuming excess protein can convert to carbohydrates, potentially disrupting ketosis.
Animal-model results don't translate to the human protocol being recommended.
The headline effect shrinks once you account for trial quality.
The headline effect shrinks once you account for trial quality.
The headline effect shrinks once you account for trial quality.
Most of the support comes from short or small studies.